IDEXX Laboratories, Inc. (IDXX)

US — Healthcare Sector
Peers: ZTS  BDX  A  COR  VEEV  IQV  EW  ARGX  ALNY  CAH 

Automate Your Wheel Strategy on IDXX

With Tiblio's Option Bot, you can configure your own wheel strategy including IDXX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol IDXX
  • Rev/Share 52.0302
  • Book/Share 19.4914
  • PB 38.6262
  • Debt/Equity 0.1643
  • CurrentRatio 1.1799
  • ROIC 0.3809

 

  • MktCap 60118469330.0
  • FreeCF/Share 11.9054
  • PFCF 63.0455
  • PE 58.693
  • Debt/Assets 0.0757
  • DivYield 0
  • ROE 0.6778

 

  • Rating B
  • Score 3
  • Recommendation Neutral
  • P/E Score 1
  • DCF Score 3
  • P/B Score 1
  • D/E Score 2

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Upgrade IDXX Stifel Hold Buy -- $700 Oct. 31, 2025
Initiation IDXX UBS -- Neutral -- $720 Oct. 1, 2025
Reiterated IDXX BTIG Research -- Buy $545 $785 Aug. 5, 2025
Initiation IDXX Jefferies -- Buy -- $625 July 1, 2025

News

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
IDXX
Published: February 13, 2025 by: Business Wire
Sentiment: Neutral

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 27, 9:05 am – 9:45 am EST – Mike Erickson, PhD, Executive Vice President, and General Manager, Point of Care Diagnostics and Telemedicine, and Andrew Emerson, Senior Vice President, Corporate and CAG Finance, will participate in a fireside chat at the virtual BofA Securities Animal Health Summit. Monday, March.

Read More
image for news IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
IDEXX Laboratories And Its Real Value
IDXX
Published: February 10, 2025 by: Seeking Alpha
Sentiment: Positive

IDEXX Laboratories stock has shown consistent long-term annualized growth of 24.75%. Despite a tough year with a 20% loss, IDEXX remains strong, fundamentally. IDEXX's innovative products and international growth offset declining US clinical visits, projecting an 11.54% annual EPS growth over the next five years.

Read More
image for news IDEXX Laboratories And Its Real Value

About IDEXX Laboratories, Inc. (IDXX)

  • IPO Date 1991-06-21
  • Website https://www.idexx.com
  • Industry Medical - Diagnostics & Research
  • CEO Jonathan J. Mazelsky
  • Employees 11000
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.